Related Experiment Video
Updated: Jun 4, 2026
09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
The IL1alpha-S100A13 heterotetrameric complex structure: a component in the non-classical pathway for interleukin
1Department of Chemistry, National Tsing Hua University, Hsinchu 30013, Taiwan.
The Journal of Biological Chemistry
|January 29, 2011
Summary
Interleukin 1α (IL1α) is crucial for cancer growth. Researchers studied the IL1α-S100A13 complex, key to IL1α release, to find new cancer treatment strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Interleukin 1α (IL1α) is a cytokine involved in angiogenesis, cell proliferation, and tumor growth.
- IL1α's biological effects are mediated by IL1 receptors (IL1Rs) after extracellular release.
- IL1α release occurs via a non-classical pathway involving a multiprotein complex with S100A13.
Purpose of the Study:
- To investigate the molecular mechanisms of IL1α release.
- To understand the structure of the IL1α-S100A13 complex.
- To identify potential therapeutic targets for cancer treatment by inhibiting IL1α release.
Main Methods:
- Structural analysis of the IL1α-S100A13 tetrameric complex.
- Biochemical assays to study complex formation and IL1α release.
Main Results:
- The study elucidated the structure of the IL1α-S100A13 tetrameric complex.
- This complex is identified as a critical component in the non-classical IL1α release pathway.
Conclusions:
- Inhibiting the IL1α-S100A13 complex formation presents a promising strategy for cancer therapy.
- Understanding this complex's structure is vital for developing targeted anti-cancer drugs.
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:28Protein Translocation Machinery on the ER Membrane
The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:34Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...